The use of oral beta-blockers and clinical outcomes in patients with non-ST-segment elevation acute coronary syndromes: a long-term follow-up study (2018)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1007/s10557-018-6818-6
- Subjects: SÍNDROME CORONARIANA AGUDA; BETA-BLOQUEADORES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Cardiovascular drugs and therapy
- ISSN: 0920-3206
- Volume/Número/Paginação/Ano: v. 32, n. 5, p. 435-442, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
NICOLAU, José Carlos et al. The use of oral beta-blockers and clinical outcomes in patients with non-ST-segment elevation acute coronary syndromes: a long-term follow-up study. Cardiovascular drugs and therapy, v. 32, n. 5, p. 435-442, 2018Tradução . . Disponível em: https://doi.org/10.1007/s10557-018-6818-6. Acesso em: 30 abr. 2024. -
APA
Nicolau, J. C., Furtado, R. H. M., Baracioli, L. M., Lara, L. M., Dalcoquio, T. F., Scanavini Junior, M. A., et al. (2018). The use of oral beta-blockers and clinical outcomes in patients with non-ST-segment elevation acute coronary syndromes: a long-term follow-up study. Cardiovascular drugs and therapy, 32( 5), 435-442. doi:10.1007/s10557-018-6818-6 -
NLM
Nicolau JC, Furtado RHM, Baracioli LM, Lara LM, Dalcoquio TF, Scanavini Junior MA, Pereira CAC, Lima VM, Goncalves TM, ColodettI R. The use of oral beta-blockers and clinical outcomes in patients with non-ST-segment elevation acute coronary syndromes: a long-term follow-up study [Internet]. Cardiovascular drugs and therapy. 2018 ; 32( 5): 435-442.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1007/s10557-018-6818-6 -
Vancouver
Nicolau JC, Furtado RHM, Baracioli LM, Lara LM, Dalcoquio TF, Scanavini Junior MA, Pereira CAC, Lima VM, Goncalves TM, ColodettI R. The use of oral beta-blockers and clinical outcomes in patients with non-ST-segment elevation acute coronary syndromes: a long-term follow-up study [Internet]. Cardiovascular drugs and therapy. 2018 ; 32( 5): 435-442.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1007/s10557-018-6818-6 - Síndrome coronariana aguda com elevação do segmento St: tratamento medicamentoso
- Isquemia miocárdica como manifestação inicial de arterite de Takaysu
- Prasugrel, ticagrelor e antagonista do receptor da trombina nas síndromes isquêmicas miocárdicas instáveis com e sem supradesnível do segmento ST
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States
- Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy
- Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial
- Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome
Informações sobre o DOI: 10.1007/s10557-018-6818-6 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
